The present invention relates to an adjuvant derived from human lymphocytes. The adjuvant can be used in combination with traditional vaccines or cancer immunotherapy, to enhance the response of the patient's immune system to the vaccine or other immunotherapeutic agent. The adjuvant is derived from the supernatant collected from cultured activated lymphocytes.
申请公布号
EP1599170(B1)
申请公布日期
2013.01.16
申请号
EP20040775788
申请日期
2004.02.20
申请人
HASUMI LLC (DBA SHUKOKAI INTERNATIONAL);UNIVERSITY OF MARYLAND
发明人
HASUMI, KENICHIRO;MANN, DEAN, LEO;HANKEY, KIM, GRAULICH;HOLT, KRISTINA, MICHELLE
